Advertisement
Screener

TECTONIC THERAPEUTIC, INC. (TECX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

TECTONIC THERAPEUTIC, INC. Cash Flow Breakdown

Cash flow breakdown shows where TECTONIC THERAPEUTIC, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $60.08M went out.
  • Fiscal year ended 2025-12-31: from investing, $138.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $173.35M came in.
  • Fiscal year ended 2025-12-31: change in cash, $113.04M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$60.08M-$138.00K-$17.00K$1.23M$172.14M*$113.04M
2024-12-31-$59.08M-$156.00K$0.00$1.62M$170.09M*$112.47M
2023-12-31-$40.68M-$279.00K$121.00K$33.63M*-$7.20M
2022-12-31-$97.21M-$267.00K$0.00$204.00K-$97.21M
2021-12-31-$98.03M-$2.46M$15.00M$920.00K$14.45M*-$70.11M
2020-12-31-$98.80M-$1.18M$270.00K$172.35M*$72.64M
2019-12-31-$67.67M-$1.58M$129.47M$529.00K*$60.74M
2018-12-31-$37.65M-$1.83M$104.01M$56.27M*$120.81M
2017-12-31-$16.38M-$383.00K$17.37M*$606.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$21.45M*-$59.00K*-$77.00K*$44.00K*$11.71M*
2026-03-31-$18.41M-$19.00K-$412.00K$100.00K$1.16M*-$17.49M
2025-12-31-$14.46M*$0.00*$0.00*$59.00K*
2025-09-30-$17.82M*-$166.00K*$0.00*$6.00K*
2025-06-30-$14.72M*$55.00K*-$17.00K*$194.00K*-$4.35M*
2025-03-31-$13.08M-$27.00K$0.00$972.00K$177.15M*$165.01M
2024-12-31-$16.82M*-$3.00K*$899.00K*-$1.97M*
2024-09-30-$19.60M*-$153.00K*$77.00K*-$6.36M*
2024-06-30-$13.38M*$4.00K*$644.00K*$179.09M*
2024-03-31-$9.27M-$4.00K$4.00K-$672.00K*-$10.02M
2023-12-31-$11.66M*-$50.00K*$120.00K*$34.01M*
2023-09-30-$8.48M*-$7.00K*$0.00*
2023-06-30-$259.00K*-$214.00K*-$41.00K*
2023-03-31-$20.28M-$8.00K$13.00K-$20.24M
2022-12-31-$23.67M*$0.00*$1.00K*
2022-09-30-$16.41M*-$86.00K*$60.00K*
2022-06-30-$29.11M*-$149.00K*
2022-03-31-$28.01M-$32.00K$0.00-$27.90M
2021-12-31-$25.90M*-$850.00K*$48.00K*$14.90M*
2021-09-30-$24.82M*-$267.00K*$0.00*
2021-06-30-$19.96M*-$1.23M*$0.00*$14.61M*
2021-03-31-$27.34M-$115.00K$850.00K-$51.00K-$26.66M
2020-12-31-$30.49M*-$81.00K*$114.00K*$70.59M*
2020-09-30-$24.86M*-$31.00K*$60.00K*
2020-06-30-$21.02M*-$488.00K*$61.00K*$8.13M*
2020-03-31-$22.43M-$577.00K$93.63M$70.65M
2019-12-31-$18.58M*-$766.00K*$3.00K*
2019-09-30-$13.38M*-$78.00K*$9.00K*$129.47M*
2019-06-30-$17.96M*-$401.00K*$238.00K*
2019-03-31-$17.74M-$340.00K$252.00K-$17.83M
2018-12-31-$11.43M*-$234.00K*
2018-09-30-$11.98M*-$1.20M*-$3.25M*
2018-06-30-$8.25M*-$137.00K*$105.47M*
2018-03-31-$5.98M-$263.00K$58.21M*$51.97M
2017-12-31-$8.83M*-$81.00K*$13.97M*
2017-09-30-$3.10M*-$240.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Entera Bio Ltd. (ENTX)$0.485B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41